Live from the NIH registry
Studies recruiting near Salinas right now
Top 25 of 46 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Central Coast Nephrology Medical Corp — Salinas, California (1.5 mi)
· Sponsor: CSL Behring
Galleri® in the Medicare Population.
Cancer
N/A
Interventional 50,000 participants sought
Sutter Valley Hospitals PAMF Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: GRAIL, Inc.
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Phase 2, Phase 3
Interventional 189 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: National Cancer Institute (NCI)
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Monterey, California (15.8 mi)
· Sponsor: AstraZeneca
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Anxiety, Mood Disorders
N/A
Interventional 156 participants sought
Ohana Center for Child and Adolescent Behavioral Health — Monterey, California (15.8 mi)
· Sponsor: Stanford University
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: NRG Oncology
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
N/A
Observational 130 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi)
· Sponsor: N-Power Medicine
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: NRG Oncology
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Dominican Santa Cruz Hospital — Santa Cruz, California (29.6 mi)
· Sponsor: NRG Oncology
Toddlers' Responses to Strangers
Social Behavior
N/A
Observational 100 participants sought
Social Science 2 Building — Santa Cruz, California (29.6 mi)
· Sponsor: University of California Santa Cruz
Babies' Brain Responses to Strangers
Infant Development
N/A
Observational 100 participants sought
Social Science 2 Building — Santa Cruz, California (29.6 mi)
· Sponsor: University of California Santa Cruz
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
Middle Schools, School Exclusion
N/A
Interventional 5,076 participants sought
Soquel Union Elementary School District — Capitola, California (26.6 mi)
· Sponsor: University of Oregon
An External Control Arm Study in Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
N/A
Observational 650 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi)
· Sponsor: N-Power Medicine
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: NRG Oncology
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Pacific Cancer Care - Oncology — Monterey, California (15.8 mi)
· Sponsor: Stemline Therapeutics, Inc.
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Salinas, California (1.5 mi)
· Sponsor: Medtronic
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma
Phase 2
Interventional 152 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network